Lumos Diagnostics Holdings Limited Price Chart
Lumos Diagnostics Holdings Limited LDX.XA Financial and Trading Overview
| Lumos Diagnostics Holdings Limited stock price | 0.06 AUD |
| Previous Close | 0.01 AUD |
| Open | 0.01 AUD |
| Bid | 0.01 AUD x N/A |
| Ask | 0 AUD x N/A |
| Day's Range | 0.01 - 0.01 AUD |
| 52 Week Range | 0.01 - 0.18 AUD |
| Volume | 35.93K AUD |
| Avg. Volume | 148.09K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LDX.XA Valuation Measures
| Enterprise Value | 6.93M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.25 |
| Enterprise Value/Revenue | 0.602 |
| Enterprise Value/EBITDA | -0.343 |
Trading Information
Lumos Diagnostics Holdings Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -90.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.18 AUD |
| 52 Week Low | 0.01 AUD |
| 50-Day Moving Average | 0.03 AUD |
| 200-Day Moving Average | 0.05 AUD |
LDX.XA Share Statistics
| Avg. Volume (3 month) | 148.09K AUD |
| Avg. Daily Volume (10-Days) | 115.13K AUD |
| Shares Outstanding | N/A |
| Float | 131.46M |
| Short Ratio | N/A |
| % Held by Insiders | 44.32% |
| % Held by Institutions | 20.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -194.49% |
| Gross Margin | 6.48% |
| EBITDA Margin | -175.67% |
Management Effectiveness
| Return on Assets (ttm) | -31.28% |
| Return on Equity (ttm) | -144.52% |
Income Statement
| Revenue (ttm) | 11.52M AUD |
| Revenue Per Share (ttm) | 0.06 AUD |
| Quarterly Revenue Growth (yoy) | -2.19% |
| Gross Profit (ttm) | 1.19M AUD |
| EBITDA | -20229000 AUD |
| Net Income Avi to Common (ttm) | -41200000 AUD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 783K AUD |
| Total Cash Per Share (mrq) | 0.004 AUD |
| Total Debt (mrq) | 4.78M AUD |
| Total Debt/Equity (mrq) | 43.8 AUD |
| Current Ratio (mrq) | 0.542 |
| Book Value Per Share (mrq) | 0.052 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12323000 AUD |
| Levered Free Cash Flow (ttm) | -5559125 AUD |
Profile of Lumos Diagnostics Holdings Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | Level 4 |
| ZIP | 3205 |
| Phone | 61 3 9087 1598 |
| Website | https://lumosdiagnostics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Q&A For Lumos Diagnostics Holdings Limited Stock
What is a current LDX.XA stock price?
Lumos Diagnostics Holdings Limited LDX.XA stock price today per share is 0.06 AUD.
How to purchase Lumos Diagnostics Holdings Limited stock?
You can buy LDX.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lumos Diagnostics Holdings Limited?
The stock symbol or ticker of Lumos Diagnostics Holdings Limited is LDX.XA.
How many shares does Lumos Diagnostics Holdings Limited have in circulation?
The max supply of Lumos Diagnostics Holdings Limited shares is 0.
What is Lumos Diagnostics Holdings Limited Price to Earnings Ratio (PE Ratio)?
Lumos Diagnostics Holdings Limited PE Ratio is now.
What was Lumos Diagnostics Holdings Limited earnings per share over the trailing 12 months (TTM)?
Lumos Diagnostics Holdings Limited EPS is 0 AUD over the trailing 12 months.